These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4163289)

  • 1. [Studies on the phytol metabolism in lipoidosis heredopathia atactica polyneuritiformis (Refsum's syndrome). The transformation of 3H-phytol into the 3,7,11,15-tetramethylhexadecanoic acid (phytanic acid) of the plasma lipoid fractions].
    Kahlke W; Wagener H; Dieckmann H
    Klin Wochenschr; 1965 Dec; 43(24):1345-7. PubMed ID: 4163289
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion of H3-phytol to phytanic acid and its incorporation into plasma lipid fractions in heredopathia atactica polyneuritiformis.
    Kahlke W; Wagener H
    Metabolism; 1966 Aug; 15(8):687-93. PubMed ID: 4166674
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heredopathia atactica polyneuritiformis. Hexadecanoic acid storage disease (Refsum's disease). Definition, treatment and pathogenesis. A short review].
    Refsum S
    Psychiatr Neurol Med Psychol Beih; 1977; 22-23():11-8. PubMed ID: 95656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ON THE PRESENCE OF 3,7,11,15-TETRAMETHYLHEXADECANOIC ACID (PHYTANIC ACID) IN THE CHOLESTEROL ESTERS AND OTHER LIPOID FRACTIONS OF THE ORGANS IN A CASE OF A DISEASE OF UNKNOWN ORIGIN (POSSIBLY HEREDOPATHIA ATACTICA POLYNEURITIFORMIS, REFSUM'S SYNDROME)].
    KLENK E; KAHIKE W
    Hoppe Seylers Z Physiol Chem; 1963; 333():133-9. PubMed ID: 14058273
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in sterol and phospholipid fatty acid composition in Refsum's disease fibroblasts grown in the presence of phytol.
    Friedman KJ; Shapiro SS
    Clin Physiol Biochem; 1985; 3(5):249-56. PubMed ID: 2414050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heredopathia atactica polyneuritiformis phytanic-acid storage disease, Refsum's disease:" a biochemically well-defined disease with a specific dietary treatment.
    Refsum S
    Arch Neurol; 1981 Oct; 38(10):605-6. PubMed ID: 6170281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heredopathia atactica polyneuritiformis (Refsum's Disease): a second trial of dietary therapy in two patients.
    Kark RA; Engel WK; Blass JP; Steinberg D; Walsh GO
    Birth Defects Orig Artic Ser; 1971 Feb; 7(1):53-5. PubMed ID: 4141911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Refsum's syndrome (Heredopathia atactica polyneuritiformis) and phytic acid].
    Thiele OW
    Hippokrates; 1970 Jun; 41(2):255-6. PubMed ID: 4193404
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
    Malmendier CL; Jonniaux G; Voet W; Van Den Bergen CJ
    Biomedicine; 1974 Nov; 20(6):398-407. PubMed ID: 4141904
    [No Abstract]   [Full Text] [Related]  

  • 10. Nutritional and metabolic aspects of heredopathia atactica polyneuritiformis (Refsum's syndrome).
    Lenk W
    Nutr Metab; 1974; 16(6):366-74. PubMed ID: 4135766
    [No Abstract]   [Full Text] [Related]  

  • 11. Heredopathia atactica polyneuritiformis (Refsum's disease): 1. Clinical features and dietary management.
    Masters-Thomas A; Bailes J; Billimoria JD; Clemens ME; Gibberd FB; Page NG
    J Hum Nutr; 1980 Aug; 34(4):245-50. PubMed ID: 6157716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stereochemistry of phytanic acid in Refsum's syndrome.
    Lough AK
    Lipids; 1970 Feb; 5(2):201-3. PubMed ID: 4191055
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the biochemical defect in heredopathia atactica polyneuritiformis (Refsum's disease).
    Eldjarn L; Try K; Stokke O
    Pathol Eur; 1968; 3(2):459-67. PubMed ID: 4176999
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phytol and phytanic acid in 2 cases of hereditary chronic polyneuropathy with uncertain classification: correlations with Refsum's disease].
    Livrea P
    Acta Neurol (Napoli); 1973; 28(1):47-59. PubMed ID: 4122245
    [No Abstract]   [Full Text] [Related]  

  • 15. Di-, mono- and nonphytanyl triglycerides in the serum: a sensitive parameter of the phytanic acid accumulation in Refsum's disease.
    Molzer B; Bernheimer H; Barolin GS; Höfinger E; Lenz H
    Clin Chim Acta; 1979 Jan; 91(2):133-40. PubMed ID: 83207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of plasma phytanic acid levels in adults.
    Britton TC; Gibberd FB; Clemens ME; Billimoria JD; Sidey MC
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):891-4. PubMed ID: 2475586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refsum's syndrome. Heredopathia atactica polyneuritiformis.
    Nevin NC; Cumings JN; McKeown F
    Brain; 1967 Jun; 90(2):419-28. PubMed ID: 4165695
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of thin-layer chromatography for the preliminary diagnosis of Refsum's disease (Heredopathia atactica polyneuritiformis).
    Karlsson KA; Norrby A; Samuelsson B
    Biochim Biophys Acta; 1967 Aug; 144(1):162-4. PubMed ID: 4168043
    [No Abstract]   [Full Text] [Related]  

  • 19. Absorption of chlorophyll phytol in normal man and in patients with Refsum's disease.
    Baxter JH
    J Lipid Res; 1968 Sep; 9(5):636-41. PubMed ID: 4177872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange.
    Gibberd FB; Billimoria JD; Page NG; Retsas S
    Lancet; 1979 Mar; 1(8116):575-8. PubMed ID: 85164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.